Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.93M | -38.91M | -63.84M | -25.14M | -49.51M |
| Total Depreciation and Amortization | 55.40M | 55.72M | 56.11M | 60.02M | 49.92M |
| Total Amortization of Deferred Charges | 36.68M | 36.68M | 38.08M | 39.20M | 42.23M |
| Total Other Non-Cash Items | 13.59M | 11.06M | 14.80M | 9.56M | 32.61M |
| Change in Net Operating Assets | 27.72M | 107.00K | -35.63M | 4.10M | 24.01M |
| Cash from Operations | 106.46M | 64.66M | 9.52M | 87.74M | 99.26M |
| Capital Expenditure | -1.21M | -928.00K | -1.66M | -2.62M | -2.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | -16.60M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.61M | -40.66M | -34.86M | -31.70M | -29.84M |
| Cash from Investing | -30.82M | -41.59M | -36.52M | -34.32M | -48.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 417.00K | 875.00K | 399.00K | 1.10M | 517.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -2.85M | 1.00K | -4.11M |
| Cash from Financing | 417.00K | 875.00K | -2.45M | 1.10M | -3.59M |
| Foreign Exchange rate Adjustments | -492.00K | -337.00K | -891.00K | 308.00K | -324.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.56M | 23.61M | -30.35M | 54.84M | 46.63M |